Clinical Trials in Tulsa, United States
Locations / Tulsa, United States
Delta Trials records 2,436 clinical trials conducted in Tulsa, United States, making it a notable site of clinical research activity. These trials across 2,610 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 271 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Tulsa has changed over time.
2436
Total Trials
2610
Conditions
271
Terminated since 2020
Browse by condition (2610 total)
- Breast cancer 65 trialsAll Breast cancer trials
- Rheumatoid arthritis 55 trialsAll Rheumatoid arthritis trials
- Atopic dermatitis 45 trialsAll Atopic dermatitis trials
- Asthma 43 trialsAll Asthma trials
- Crohn's disease 39 trialsAll Crohn's disease trials
- Lung cancer 36 trialsAll Lung cancer trials
- Diabetes mellitus, type 2 36 trialsAll Diabetes mellitus, type 2 trials
- Alzheimer's disease 29 trialsAll Alzheimer's disease trials
- Ovarian cancer 29 trialsAll Ovarian cancer trials
- Prostate cancer 29 trialsAll Prostate cancer trials
- HIV infections 27 trialsAll HIV infections trials
- Non-small cell lung cancer 26 trialsAll Non-small cell lung cancer trials
- Recurrent ovarian carcinoma 25 trialsAll Recurrent ovarian carcinoma trials
- Colorectal cancer 25 trialsAll Colorectal cancer trials
- Hypertension 23 trialsAll Hypertension trials
- Leukemia 23 trialsAll Leukemia trials
- Heart failure 21 trialsAll Heart failure trials
- Systemic lupus erythematosus 20 trialsAll Systemic lupus erythematosus trials
- Major depressive disorder 20 trialsAll Major depressive disorder trials
- Parkinson's disease 20 trialsAll Parkinson's disease trials